Trial · NCT03221283
The Application of Music Therapy in Female Amphetamine Use Disorder
NCT03221283, Not applicable, Completed, Shanghai Mental Health Center
3 sourcestrials-2026-11-12-0.4.0
Cite this record
ConductScience Library. The Application of Music Therapy in Female Amphetamine Use Disorder. Trials, record NCT03221283. Release trials-2026-11-12-0.4.0, 12 Nov 2026. https://conductscience.org/library/trials/NCT03221283
On this page
Trial
As registered on ClinicalTrials.gov, in the graph's capture of the registry.
- Title
- The Application of Music Therapy in Female Amphetamine Use Disorder
- NCT number
- NCT03221283
- Status
- Completed
- Phases
- Not applicable
- Enrollment
- 40 participants, actual
- Lead sponsor
- Shanghai Mental Health Center
- Conditions
- Amphetamine Addiction
- Interventions
- Music therapy group
- First posted
- 2017-07-18
- Last updated
- 2018-11-20
Source ClinicalTrials.gov
Registered outcomes7
Each outcome the trial registered, primary first, in ClinicalTrials.gov's words.
| List | Outcome | Time frame | Description |
|---|---|---|---|
| Primary | Change from Baseline Depression status assessed by Self-rating Depression Scale (SDS) at 4 months. | Baseline, 2 months,4 months, and 7months | evaluate all participants' depression status by Self-rating Depression Scale (SDS) |
| Secondary | Anxiety status assessed by Self-rating Anxiety Scale (SAS) | Baseline, 2 months,4 months, and 7months | evaluate all participants' anxiety status by Self-rating Anxiety Scale (SAS) |
| Secondary | Change from Baseline Craving for ATS assessed by Visual Analog Scales (VAS) | Baseline, 2 months,4 months, and 7months | evaluate all participants' craving for ATS by Visual Analog Scales (VAS) |
| Secondary | Empathy ability assessed by Interpersonal Reactivity Index-C(IRI-C) | Baseline, 2 months,4 months, and 7months | evaluate all participants' Empathy ability by Interpersonal Reactivity Index-C(IRI-C) |
| Secondary | Motivation for treatment assessed by Stages of Change Readiness and Treatment Eagerness Scale(SOCRATES) | Baseline, 2 months,4 months, and 7months | evaluate all participants' motivation for treatment assessed by Stages of Change Readiness and Treatment Eagerness Scale(SOCRATES) |
| Secondary | Change from Baseline emotional status assessed by emotional STROOP paradigm | Baseline, 2 months,4 months, and 7months | evaluate all participants' emotional status by emotional STROOP paradigm |
| Secondary | Sleep status assessed by Pittsburgh Sleep Quality Index(PSQI) | Baseline, 2 months,4 months, and 7months | evaluate all participants' sleep status by Pittsburgh Sleep Quality Index(PSQI) |
Source ClinicalTrials.gov
Outcomes0
Each outcome the trial posted results for, in ClinicalTrials.gov's words.
None in this release.
Results by group0
Each measurement the trial posted, group by group, in the words and numbers it posted.
None in this release.
Participant flow0
How many started, completed or left each group, period by period.
None in this release.
Adverse events0
Each adverse event the trial posted, group by group: the participants affected out of those at risk.
None in this release.
Adverse event totals0
The totals the trial posted for each group.
None in this release.
Papers0
The papers the trial lists on ClinicalTrials.gov.
None in this release.
Grants0
The grants NIH RePORTER links to the trial, newest funded first: NIH's, and some of AHRQ's, CDC's, FDA's and VA's. Each shows its title, principal investigators, organization and funder in its newest year.
None in this release.
Trial comparisons0
Comparisons of the trial's two groups, calculated by ConductScience from the counts it posted.
None in this release.
Tests2
The ConductCognition tests this trial's registered outcomes name, as ScienceGraph matched them in trial-tests-2026-11-12-0.2.1.
| Test | Named as | Source |
|---|---|---|
| Emotional Stroop Task | Secondary outcome | ConductCognition |
| Stroop Color-Word Test | Secondary outcome | ConductCognition |
Source
- Release
- trials-2026-11-12-0.4.0
- Release manifest SHA-256
- 0f4a8d8c48aee2a7573ae0fa94ecbeab70c1adbe449bbc95c424bc7d3e97b9d4
- Registry capture
- 2026-11-12
- Results copy, AACT
- 2026-03-23
- NIH clinical studies file
- 2026-11-13
Source ClinicalTrials.gov
Sources 3
- ClinicalTrials.gov's posted results, through CTTI's AACTFreely available. Acknowledgement requested
- ClinicalTrials.govNone stated
- NIH RePORTER's clinical studies and project filesPublic domain
Each source's terms
- ClinicalTrials.gov's posted results, through CTTI's AACTClinicalTrials.gov data via Aggregate Analysis of ClinicalTrials.gov (AACT), CTTI. CTTI makes its materials freely available and requests acknowledgement. https://aact.ctti-clinicaltrials.org/documentation/299
- ClinicalTrials.govnone stated
- NIH RePORTER's clinical studies and project filesPublic domain (NIH RePORTER)
ClinicalTrials.gov's data carry an international copyright outside the United States: https://clinicaltrials.gov/about-site/terms-conditions.
For software
Read this trial from software.
The record and each of its lists are JSON, twenty rows a page. No key.
GET https://conductscience.org/api/trials/v1/NCT03221283
GET https://conductscience.org/api/trials/v1/NCT03221283/registered